End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.42 CNY | +0.11% |
|
-3.76% | +4.33% |
05-27 | Morgan Stanley Starts Pacific Shuanglin Bio-pharmacy at Overweight With 37 Yuan Price Target | MT |
05-23 | Pacific Shuanglin Bio-pharmacy's Unit Gets Nod to Trial Intravenous Human Immunoglobulin | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.33% | 2.86B | |
+1.43% | 94.45B | |
-0.66% | 38.9B | |
-14.58% | 32.56B | |
-13.37% | 15.98B | |
-2.19% | 13.82B | |
-13.59% | 11.34B | |
+158.88% | 9.81B | |
-52.04% | 9.67B | |
+1.87% | 8.91B |
- Stock Market
- Equities
- 000403 Stock
- News Pacific Shuanglin Bio-pharmacy Co., LTD
- Pacific Shuanglin Bio-pharmacy's Unit Gets Nod to Trial Intravenous Human Immunoglobulin